Venture
Showing 151–156 of 156 results
-
VentureVoronoi
Voronoi is a biotech company that develops novel kinase inhibitors and target protein degraders. They have about 120 employees, each specialized in Synthesis/Structural Biology, Biology, and AI/Molecular Modeling, etc, who have great expertise in kinase inhibitors.
-
VentureVT Bio (GMP Bio)
Established in July 2000, a drug development research company on next-generation cell therapy and natural products through links to industry-academic associations and a number of national projects.
-
VentureWellmarker Bio
Wellmarker Bio is a company that has developed biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center. Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developing new cancer drugs.
-
VentureY-Biologics
Y-Biologics is a biotech company that focuses on the development of innovative immunotherapies using its dual antibody platform. They have established a global competitive human antibody library technology and a next-generation immunotherapy technology, a new dual antibody format. They are developing a number of effective immunotherapies based on these technologies.
-
VentureYiPSCELL
YiPSCELL conducts clinical immunology & stem cell research and aims to proceed induced pluripotent stem cell research and develop therapeutics based on our research.
-
VentureYouth Bio Global
Youth Bio is a company that focuses on the development of stem cell therapies. They aim to improve the quality of life for patients suffering from congenital and incurable diseases5.